Exodus Point Capital Management, LP Longboard Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$17.0 - $27.03 $668,865 - $1.06 Million	39,345 Added 95.57%	80,514 $2.18 Million
Q1 2024 May 14, 2024	BUY	$18.89 - $26.06 $777,682 - $1.07 Million	41,169 New	41,169 $889,000
Q4 2021 Feb 11, 2022	SELL	$4.75 - $9.45 $57,346 - $114,089	-12,073 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.65 - $11.36 $104,431 - $137,149	12,073 New	12,073 $107,000
Q2 2021 Aug 16, 2021	SELL	$7.95 - $17.3 $119,337 - $259,690	-15,011 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.0 - $16.89 $240,176 - $253,535	15,011 New	15,011 $246,000

126

34.9M

28.9K

13.9K

Ticker LBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,586,000
Market Cap $815M
Description
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.